GSK2324
Modify Date: 2025-08-25 17:05:41
GSK2324 structure
|
Common Name | GSK2324 | ||
|---|---|---|---|---|
| CAS Number | 1020567-30-9 | Molecular Weight | 533.40200 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C29H22Cl2N2O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of GSK2324GSK2324 (Compd 1c) is a FXR agonist for diabetes study, with an EC50 of 120 nM. GSK2324 exhibits t1/2 values of 84 min (mouse), 170 min (rat), 110 min (beagle) and 120 min (cyno), respectively[1]. |
| Name | GSK-2324 |
|---|---|
| Synonym | More Synonyms |
| Description | GSK2324 (Compd 1c) is a FXR agonist for diabetes study, with an EC50 of 120 nM. GSK2324 exhibits t1/2 values of 84 min (mouse), 170 min (rat), 110 min (beagle) and 120 min (cyno), respectively[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C29H22Cl2N2O4 |
|---|---|
| Molecular Weight | 533.40200 |
| Exact Mass | 532.09600 |
| PSA | 85.45000 |
| LogP | 8.26420 |
| 6-[4-({[3-(2,6-dichlorophenyl)-5-(1-methylethyl)-4-isoxazolyl]methyl}oxy)phenyl]-2-quinolinecarboxylic acid |